Skip to main content
OpenTrials

Clinical trial condition

Histiocytic Disorders, Malignant

Explore clinical trials studying Histiocytic Disorders, Malignant. Study availability and eligibility vary by location and protocol.

260 public trials 43 recruiting studies

Histiocytic Disorders, Malignant trial results

Conditions
CAR T Cell Therapy, DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +6 more
Locations
  • National Cancer Center Hospital Tokyo, Japan
  • Toranomon Hospital Tokyo, Japan
  • Juntendo University Hospital Tokyo, Japan
  • Tokyo Metropolitan Komagome Hospital Tokyo, Japan
Conditions
Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +22 more
Locations
  • NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands
  • NL-Almelo-ZGTALMELO Almelo, Netherlands
  • NL-Amstelveen-AMSTELLAND Amstelveen, Netherlands
  • NL-Apeldoorn-GELREAPELDOORN Apeldoorn, Netherlands
View all 25 locations
Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States